E
TGAN

Ergoteles’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Ergoteles’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,349
Closed -$61.7K – 1881
2022
Q4 		$61.7K Buy
+11,349
New +$66.8K ﹤0.01% 1275
2022
Q2 		– Sell
-18,900
Closed -$134K – 2090
2022
Q1 		$134K Buy
+18,900
New +$133K 0.01% 1073

Other funds holding TGAN

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ergoteles's TGAN Position: Q1 2023 in Review

Ergoteles sold out of Transphorm, Inc. Common Stock (TGAN) in Q1 2023, closing a stake of 11,349 shares — an estimated $61.7K sold.

Ergoteles first reported a position in TGAN in Q1 2022 and held it in 2 quarters. The position peaked at $134K in Q1 2022. 39 funds tracked by Wall St. Rank hold TGAN as of Q1 2023.

  • Ergoteles reported no remaining Transphorm, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 11,349 Transphorm, Inc. Common Stock shares in Q1 2023, an estimated $61.7K.
  • Ergoteles first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Ergoteles's Transphorm, Inc. Common Stock position peaked at $134K in Q1 2022.
  • 39 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.